RANCHO CORDOVA, Calif., June 12, 2014 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, announced today that it intends to offer Units consisting of its shares of common stock and warrants to purchase shares of common stock in an underwritten public offering. The shares of common stock and warrants comprising the units are immediately separable. All of the Units in the offering are being sold by Cesca.
Help employers find you! Check out all the jobs and post your resume.
